Linda Janisch
- Oncology top 1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Pharmacology top 1%
- Co-authors
- Mark J. RatainJacqueline Ramı́rezEverett E. VokesSoma DasRichard L. SchilskyLalitha IyerGini F. FlemingTheodore Karrison
- Topics
- Cancer Treatment and Pharmacology (19 papers)Cancer therapeutics and mechanisms (12 papers)PI3K/AKT/mTOR signaling in cancer (10 papers)
- Cited by
- OncologyPharmacologyHepatology
- Partner nations
- United StatesChinaGermany
In The Last Decade
Linda Janisch
67 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 2.1k
- Molecular Biology 1.7k
- Pulmonary and Respiratory Medicine 738
- Cancer Research 400
- Pharmacology 358
Countries citing papers authored by Linda Janisch
This map shows the geographic impact of Linda Janisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Janisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Janisch more than expected).
Fields of papers citing papers by Linda Janisch
This network shows the impact of papers produced by Linda Janisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Janisch. The network helps show where Linda Janisch may publish in the future.
Co-authorship network of co-authors of Linda Janisch
This figure shows the co-authorship network connecting the top 25 collaborators of Linda Janisch. A scholar is included among the top collaborators of Linda Janisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Janisch. Linda Janisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 4 | |
| 3 | 20 | |
| 4 | 186 | |
| 5 | 49 | |
| 6 | 33 | |
| 7 | 60 | |
| 8 | 5 | |
| 9 | 7 | |
| 10 | 2 | |
| 11 | 25 | |
| 12 | 91 | |
| 13 | 4 | |
| 14 | 29 | |
| 15 | 1 | |
| 16 | 52 | |
| 17 | 9 | |
| 18 | 16 | |
| 19 | 69 | |
| 20 | 5 |
About Linda Janisch
Linda Janisch is a scholar working on Oncology, Molecular Biology and Immunology and Allergy, having authored 68 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (19 papers), Cancer therapeutics and mechanisms (12 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). The work is most often cited by research in Oncology (2.1k citations), Pharmacology (358 citations) and Hepatology (227 citations). Linda Janisch has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Mark J. Ratain, Jacqueline Ramı́rez, Everett E. Vokes, Soma Das, Richard L. Schilsky, Lalitha Iyer, Gini F. Fleming, Theodore Karrison, Samir D. Undevia and Charles M. Rudin. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.